Humacyte Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of 0.00% with a gross margin of -41.67%. The profit margin, also known as the revenue ...

NEW YORK, NY / ACCESSWIRE / November 24, 2024 / If you suffered a loss on your Humacyte, Inc. (NASDAQ:HUMA) investment and want to learn about a ...

On Thursday, Humacyte Inc (HUMA) stock saw a decline, ending the day at $4.84 which represents a decrease of $-0.50 or -9.36% from the prior close of $5.34. The stock opened at $5.41 and touched a low ...

"The allegations in the complaint highlight serious violations of securities laws. If proven true, Humacyte's alleged failure to disclose material information to investors is unacceptable," said Reed ...

Insiders who acquired US$775.1k worth of Humacyte, Inc.'s (NASDAQ:HUMA) stock at an average price of US$6.64 in the past 12 months may be dismayed by the recent 17% price decline. Insiders ...

Kathleen Sebelius, a director at Humacyte ($HUMA), sold 1,548 shares of the company on 09-10-2024. We received data on the trade from a recent SEC filing. This was a ...

Insiders who acquired US$775.1k worth of Humacyte, Inc.'s (NASDAQ:HUMA) stock at an average price of US$6.64 in the past 12 months may be dismayed by the recent 17% price decline. Insiders purchase ...

In the latest market close, Humacyte, Inc. (HUMA) reached $5.05, with a -1.94% movement compared to the previous day. The stock's change was less than the S&P 500's daily loss of 1.86%.

Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsLauren Marek - LifeSci AdvisorsLaura Niklason ...

HUMA Investors with Losses Encouraged to Contact the Firm ...

Kidney Week Humacyte ( (HUMA) ) has shared an announcement. Humacyte, Inc. has initiated a registered direct offering of approximately $30.0 million in common stock and warrants to an institutional ...